Article
The NQO1 rs1800566 polymorphism and risk of bladder cancer: evidence from 6,169 subjects.
Asian Pacific journal of cancer prevention : APJCP - 1 Jan 2012
Guo Zhan-Jing, Feng Chang-Long
Abstract excerpt
OBJECTIVE: The NAD(P)H:quinone oxidoreductase 1 (NQO1) rs1800566 polymorphism, leading to proline- toserine amino-acid and enzyme activity changes, has been implicated in bladder cancer risk, but individually published studies showed inconsistent results. We therefore here conducted a meta-analysis to summarize the possible association. METHODS: A systematic literature search up to August 27, 2012 was carried out...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
